ClinicalTrials.Veeva

Menu

Pulmonary Embolism Prognosis Model

Chinese Academy of Medical Sciences & Peking Union Medical College logo

Chinese Academy of Medical Sciences & Peking Union Medical College

Status

Enrolling

Conditions

Pulmonary Embolism

Treatments

Other: observation

Study type

Observational

Funder types

Other

Identifiers

NCT04411888
PUMCH--Pulmonary embolism

Details and patient eligibility

About

The purpose of this study is to analyze the clinical manifestations, imaging features, and prognosis-related factors of pulmonary embolism, and to explore the prognosis risk assessment model for Chinese patients

Full description

Patients with pulmonary embolism and aged 18 years or older were enrolled in this study.Patient demographic characteristics((age, sex, department, diagnosis, ), basic vital signs, symptoms at their admissions (hemoptysis, dyspnea, chest pain, syncope), laboratory examinations (blood lab routines, blood gas, liver and kidney function, myocardial marker), and imaging examinations (vascular ultrasonography, computed tomographic angiography, echocardiography, chest CT, CTPA, pulmonary perfusion imaging, pulmonary angiography, PET/CT) were collected by reviewing the cases. The prognostic information was collected by telephone follow-up. The follow-up end point was June 2024.

Enrollment

1,500 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Aged 18 years or older. Discharged with the diagnosis of PE from Peking Union Medical College Hospital.

Exclusion criteria

Diagnosed PE by other health care facility or transferred from other health care facility .

Without important follow-up data.

Trial contacts and locations

1

Loading...

Central trial contact

Min Peng, M.D; Juhong Shi, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems